Patents
Patents for C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394)
09/2003
09/18/2003US20030176329 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
09/17/2003CN1121410C Process for preparation of N-methyl-D-phenylalanyl-N-[1-[3-[ (aminoiminomethyl)-amino]propyl]-3,3-difluoro-2-oxohexyl]-L-prolinamide
09/12/2003WO2003074495A1 Hppars activators
09/11/2003US20030171417 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same
09/10/2003EP1194401B1 Diacylhydrazine derivatives
09/10/2003EP0783299B1 Compounds and compositions for delivering active agents
09/10/2003CN1440971A Vitronectin receptor antagnist, its preparation and use
09/09/2003CA2036770C Inhibitors of nitric oxide biosynthesis
09/04/2003WO2003071884A1 Compound containing creatine, an acid component and/or a complexing agent
09/04/2003WO2002070468A3 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
09/04/2003US20030166630 Amino acid derivatives and their use as medicines
09/02/2003US6613801 Method for the synthesis of compounds of formula I and their uses thereof
09/02/2003US6613769 Tryptase inhibitors
08/2003
08/28/2003US20030163000 Mixing together halohydrocarbon, inorganic base, and salt of unsubstituted guanidine, such that a product comprised predominately of organo guanidinium salt is formed
08/28/2003US20030162967 Having antithrombotic effect; fortherapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses; reversible inhibitors of blood clotting enzymes factor Xa and/or factor VIIa
08/28/2003US20030162838 Bactericide, antiseptic, dermally applicable composition, washing composition, antibacterial fiber aggregate, method for eradicating a microorganism, and method for inhibiting the proliferation of a microorgamism
08/28/2003US20030162661 Selective control of harmful plants in crops of useful plants
08/28/2003US20030162293 Cell transfection compositions comprising genetic material, an amphipathic compound and an enzyme inhibitor and method of use
08/27/2003CN1438992A Biocidal polymers based on guanidine salts
08/27/2003CN1119327C Method for producing N-alkyl-N'-nitroguanidines
08/26/2003US6610850 Contrast media for angiography
08/26/2003US6610329 Compositions for the delivery of antigens
08/21/2003WO2003068209A1 Metformin salts of lipophilic acids
08/21/2003US20030158442 Process for the production of nitrogen compounds
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030158226 Treating or preventing emphysema, cancer and dermatological disorders
08/21/2003US20030158038 Can develop color at high image density by the inclusion of a diazonium salt compound and a coupler as color developing components and of the guanidine compound as a base
08/20/2003EP1196378B1 Aminoguanidine bicarbonate with particular properties and method for making same
08/20/2003EP1133468B1 Method of producing n-alkyl-n'-nitroguanidine
08/20/2003EP0859591B1 Use of at least one no synthase inhibitor for treating sensitive skin
08/20/2003CN1437580A 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
08/19/2003CA2091333C Process for the production of guanidine derivatives
08/14/2003WO2003066673A1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
08/14/2003WO2003024945A3 Method for producing polyphosphates of organic bases
08/14/2003WO2002020475A3 Inhibitors of serine protease activity of matriptase or mtsp1
08/14/2003US20030153779 Acidification of a mixture resulting from oxidative direct carbonylation that contains, e.g., a quaternary ammonium salt, a phenolated, phenol and diphenylcarbonate, followed by reactive extraction; circulation; reuse
08/14/2003US20030153611 Antitumor agents promoting the detachment of endothelial cells forming tumor, inhibiting tubulin polymerization
08/14/2003US20030153523 Screening library of test compounds, each of which is attached to a solid support, with a dye-labeled RNA molecule to form a dye-labeled target RNA:support-attached test compound complex
08/14/2003US20030151019 Process for the preparation of organic solutions
08/14/2003CA2475609A1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
08/07/2003WO2003063797A2 Cycloalkyl inhibitors of potassium channel function
08/07/2003CA2474451A1 Cycloalkyl inhibitors of potassium channel function
08/06/2003EP1332127A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
08/05/2003US6602878 Acylquanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them
07/2003
07/31/2003WO2002062762A3 Potassium channel openers
07/31/2003US20030144517 Chiral fluoroquinolone arginine salt forms
07/31/2003US20030144361 Antimalarial N,N'-subistituted biguanides derived from hydroxylamines
07/31/2003US20030144311 Propanoic acid derivatives as intergrin receptor antagonists
07/30/2003EP0705100B1 Therapeutic substituted guanidines
07/30/2003CN1116279C 3-methyl-2-butenyl isoguanidine as active hyponglycemic component in yanzizhang and its preparing process
07/29/2003US6600072 Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic , and medicament containing them
07/24/2003US20030139470 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
07/17/2003WO2003057169A2 4-dedimethylamino tetracycline compounds
07/17/2003WO2003057164A2 Compounds for delivering substances into cells
07/17/2003US20030134904 Inhibitors of RNase P proteins as antibacterial compounds
07/17/2003US20030134423 Lipid aggregates (liposomes) for transfection of nucleic acids
07/17/2003US20030133953 Complexing a biologically active agent with a perturbant to reversibly transform and exposing a membrane or bilayer to the supramolecular complex
07/10/2003WO2003055849A1 Method for producing quaternary salt phenolate solutions and for regenerating and recycling quaternary salt phenolate solutions from reaction mixtures
07/10/2003WO2003055603A1 Method for separating reaction mixtures and recycling of quaternary salts and bases
07/09/2003EP1325737A1 Skin pore minimizers and skin elasticity improvers
07/09/2003EP1324981A2 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors
07/09/2003EP1324760A1 Creatine ester pronutrient compounds and formulations
07/09/2003EP1040096B1 Neuroprotective agents
07/03/2003WO2003053917A1 Guanidine compounds and pest controllers
07/03/2003WO2003053915A2 Compounds for the treatment of inflammatory disorders
07/03/2003US20030125384 Administering agent that selectively inhibits bacterial DNA replication initiation; for disease or disorder caused by or associated with E. coli or H. pylori infection
07/03/2003US20030125383 For treating or preventing emphysema, cancer and dermatological disorders
07/03/2003US20030125348 Minocycline compound substitued at 9-position by a group selected from nitro, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsufinyl, alkylsulfonyl, amino, thionitroso, arylalkynyl or carbamate, urea, and sulfonamide
07/02/2003CN1113060C Substituted 2-amino-4-alkylamino-1,3,5-triazine as herbicide
06/2003
06/26/2003WO2003051357A1 Glucagon receptor antagonists/inverse agonists
06/26/2003US20030120034 N-(2-hydroxyethyl)-2,4,6-triiodo-5-(2-(2,4,6-triiodo-3-(N-meth yl acetamido)-5-(methylcarbamyl)benzamidoacetamido)-isophthalmic acid, derivatives
06/25/2003EP1320534A1 Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds
06/25/2003CN1426391A Polyamine analogues as cytotoxic agents
06/24/2003US6583309 Ureas and compositions thereof for treating cancer, inflammation, or a viral infection
06/19/2003US20030113361 Palatable arginine compounds and uses thereof for cardiovascular health
06/19/2003US20030113291 Biocidal polymers based on guanidine salts
06/18/2003EP1140829A4 Contrast media for angiography
06/18/2003CN1111520C Matrix metalloprotease inhibitors
06/17/2003US6579890 Matrix metalloprotease inhibitors
06/12/2003WO2003048116A2 Esters and amides as ppar-alpha agonists ____________
06/12/2003WO2003048106A2 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
06/12/2003US20030109751 Reacting borate with guanidinium or imidazolidinium compound; heating; crystal structure; forming ceramic; fire retarders, microbiocide
06/12/2003US20030109547 Amidinophenylpyruvic acid derivatives
06/12/2003CA2469227A1 New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
06/12/2003CA2469193A1 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/10/2003US6576786 Reacting an n-protected carboxy-amine-cyclopentane derivative with a nitrile oxide followed by salt formation, desalting, decyclization, deprotecting and amidation
06/10/2003US6576783 Oligonucleotide protecting groups
06/04/2003EP0789578B1 Multicatalytic protease inhibitors
06/03/2003CA2053954C Process for the preparation of nitroguanidine derivatives
05/2003
05/29/2003US20030100613 Substituted imide derivatives
05/29/2003US20030100584 Highly selective inhibitors of the urokinase plasminogen activator
05/28/2003EP0814792B1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
05/28/2003CN1420863A Substd. imide derivs.
05/28/2003CN1109499C Fungicide active substance combinations
05/27/2003US6570038 Aqueous hexasubstituted guanidinium chlorides and methods for their preparation and use
05/27/2003US6569880 Bis(benzimidazole) derivatives serving as potassium blocking agents
05/22/2003WO2003042237A1 Peptide derivative, pharmaceutically acceptable salt thereof, process for producing the same, and use thereof
05/22/2003CA2465080A1 Peptide derivative and pharmaceutically acceptable salts thereof, and production process and use thereof
05/21/2003EP1311514A1 Compositions with vascular damaging activity
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 54